Multi-parametric magnetic resonance imaging as a management decision tool.

Area of Science:

• Urology
• Radiology
• Oncology

Background:

• Localized prostate cancer (PCa) management benefits from accurate imaging and lesion characterization.
• Significant overtreatment of indolent PCa necessitates improved risk stratification strategies.
• Multiparametric MRI (mpMRI) offers enhanced capabilities for prostate imaging.

Purpose of the Study:

• To evaluate the role of mpMRI in improving the management of localized prostate cancer.
• To assess mpMRI's utility in risk stratification and reducing overtreatment.
• To explore mpMRI's application in active surveillance and treatment planning.

Main Methods:

• Utilized multiparametric magnetic resonance imaging (mpMRI) for prostate cancer detection and characterization.
• Assessed mpMRI's accuracy in ruling out clinically significant PCa.
• Evaluated mpMRI's role in active surveillance and determining local disease extent.

Main Results:

• mpMRI improves detection of clinically significant PCa, minimizing sampling errors.
• mpMRI aids in ruling out significant PCa, supporting surveillance decisions and reducing overtreatment.
• mpMRI is valuable for monitoring active surveillance patients, potentially reducing biopsies.
• mpMRI assists in treatment decisions, counseling, and surgical planning by defining local disease extent.

Conclusions:

• mpMRI is an invaluable tool for managing localized prostate cancer, enhancing risk stratification and treatment decisions.
• While mpMRI has limitations, including detection of multifocal disease and need for expert interpretation, its role is expanding.
• Continued technological advancements and radiologist experience will further improve mpMRI's utility in PCa management.